Sage Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€44.20
Target price
31.12.25
€60.00
Performance (%)
-83.14%
End price
19.08.24
€7.45
Summary
This prediction ended on 19.08.24 with a price of €7.45. Massive losses of -83.14% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to BiotechBee what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Buy mit Kursziel 60,0